Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
LightSpot®-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models.
Cancers (Basel). 2021 Aug 11;13(16):4050. doi: 10.3390/cancers13164050.
Cancers (Basel). 2021.
PMID: 34439204
Free PMC article.
The New Serum-Free OptiPASS® Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.
Goisnard A, Dubois C, Daumar P, Aubel C, Depresle M, Gauthier J, Vidalinc B, Penault-Llorca F, Mounetou E, Bamdad M.
Goisnard A, et al. Among authors: vidalinc b.
Cancers (Basel). 2021 Apr 18;13(8):1945. doi: 10.3390/cancers13081945.
Cancers (Basel). 2021.
PMID: 33919619
Free PMC article.
Item in Clipboard
The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.
Dubois C, Daumar P, Aubel C, Gauthier J, Vidalinc B, Mounetou E, Penault-Llorca F, Bamdad M.
Dubois C, et al. Among authors: vidalinc b.
J Clin Med. 2019 Mar 21;8(3):397. doi: 10.3390/jcm8030397.
J Clin Med. 2019.
PMID: 30901969
Free PMC article.
Item in Clipboard
Cite
Cite